Why the study?
Tricuspid regurgitation is a frequent echocardiographic finding, but its association with prognosis and mortality independent of LVEF, RV dilation and dysfunction, and PASP remains unclear.
Does increasing severity of tricuspid regurgitation reduce long-term survival in patients undergoing echocardiography?
Does increasing severity of tricuspid regurgitation reduce long-term survival in patients undergoing echocardiography?
Moderate to severe tricuspid regurgitation is independently associated with increased mortality, regardless of left ventricular ejection fraction, right ventricular function, or pulmonary artery systolic pressure.
Supports closer monitoring in moderate or greater TR; leaves open whether intervention improves outcomes.**[[1]](https://pubmed.ncbi.nlm.nih.gov/15013122/)[[2]](https://www.jacc.org/doi/10.1016/j.jacc.2003.09.
OBJECTIVES: The goal of this study was to examine mortality associated with tricuspid regurgitation (TR) after controlling for left ventricular ejection fraction (LVEF), right ventricular (RV) dilation and dysfunction, and pulmonary artery systolic pressure (PASP). BACKGROUND: Tricuspid regurgitation is a frequent echocardiographic finding; however, the association with prognosis is unclear. METHODS: We retrospectively identified 5,223 patients (age 66.5 +/- 12.8 years; predominantly male) undergoing echocardiography at one of three Veterans Affairs Medical Center laboratories over a period of four years. Follow-up data were available for four years (mean 498 +/- 402 days). Kaplan-Meier and proportional hazards methods were used to compare differences in survival among TR grades. RESULTS: Mortality increased with increasing severity of TR. The one-year survival was 91.7% with no TR, 90.3% with mild TR, 78.9% with moderate TR, and 63.9% with severe TR. Moderate or greater TR was associated with increased mortality regardless of PASP (hazard ratio [HR] 1.31, 95% confidence interval [CI] 1.16 to 1.49 for PASP >40 mm Hg; HR 1.32, 95% CI 1.05 to 1.62 for PASP < or =40 mm Hg) and LVEF (HR 1.49, 95% CI 1.34 to 1.66 for EF <50%; HR 1.54, 95% CI 1.37 to 1.71 for EF > or =50%). When adjusted for age, LVEF, inferior vena cava size, and RV size and function, survival was worse for patients with moderate (HR 1.17, 95% CI 0.96 to 1.42) and severe TR (HR 1.31, 95% CI 1.05 to 1.66) than for those with no TR. CONCLUSIONS: We conclude that increasing TR severity is associated with worse survival in men regardless of LVEF or pulmonary artery pressure. Severe TR is associated with a poor prognosis, independent of age, biventricular systolic function, RV size, and dilation of the inferior vena cava.
No takes yet. Share an insight, caveat, or question.
Nath et al. (2004) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: